Moody D. Wharam, Jr., M.D., F.A.C.R.

Willard and Lillian Hackerman Professor of Radiation Oncology

Professor of Oncology, Radiology, Neurological Surgery and Pediatrics

1959-63

B.A.
Harvard University, Cambridge, Massachusetts

1963-65

Lt.(jg)
United States Navy Reserve, U.S.S. Blandy (DD 943)

1965-69

M.D.
University of Virginia School of Medicine, Charlottesville, Va.

1969-70

Intern, Medicine and Pediatrics
Georgetown University Medical Center, Washington, D.C.

1970-73

NIH Fellow in Radiation Therapy
Section of Radiation Oncology, University of California
Medical Center, San Francisco, California

1972

Visiting Resident Trainee
Division of Radiation Therapy, University of Virginia,
School of Medicine, Charlottesville, Virginia

1973-74

Clinical Instructor in Residence
Section of Radiation Oncology, University of California
Medical Center, San Francisco, California

1974-75

Assistant Professor of Radiology
Division of Therapeutic Radiology, Duke University
School of Medicine, Durham, North Carolina

1975-80

Assistant Professor of Oncology
The Johns Hopkins University School of Medicine

1975-80

Assistant Professor of Oncology
and Radiological Sciences
The Johns Hopkins University School of Medicine

1980-93

Associate Professor of Oncology
The Johns Hopkins University School of Medicine

1980-93

Associate Professor of Oncology and Radiological Sciences
The Johns Hopkins University School of Medicine

1993

Professor of Oncology
The Johns Hopkins University School of Medicine

1959

National Merit Scholarship, Semi-Finalist

1963

Harvard-American University Summer School Scholarship

1963

B.A. Degree cum laude Harvard University

1997

Knight Commander, Equestrian Order of the Holy Sepulchre of Jerusalem

2002

2002 Fellow, American College of Radiology

2002

“Best Doctor” citation for Radiation Oncology, Baltimore Region

2002

Awarded Fellow status by the American College of Radiology (FACR).

Publications

1. Bowers, DC, Krause, TP, Aronson, LJ, Barzi, F, Burger, PC, Carson, BS, Weingart, JD, Wharam, MD,
Melhem, ER, Cohen, KJ. Second Surgery for Recurrent Pilocytic Astrocytoma in Children.
Ped. Neurosurg 2001, 34:229-234.

2. Hawkins, M, Anderson, JR, Meza, JL, Fryer, C, Raney, RB, Ruymann, FB, Breneman, J, Qualman, SF,
Wiener, E, Wharam, MD et al. Improved Outcome for Patients with Middle Ear Rhabdomyosarcoma:
A Children’s Oncology Group Study. J Clin Oncol 2001, 19: (12) 3073-3079.

3. Williams, M, Anderson, JR, Meza, JL, Fryer, C, Raney, RB, Ruymann, FB, Breneman, SJ. Wiener, Wharam, MD et al. Intergroup Rhabdomyosarcoma study-IV: Results for Patients with Nonmetastatic Disease. J Clin Oncol 2001, 19:3091-3102.

4. Breitfeld, PP, Lyden, E, Raney, B, Teot, LA, Wharam, MD, Lobe, T, Crist, WM, Maurer, HM, Donaldson, SS, Ruymann, RB. Ifosfamide and Etoposide are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma when Administered with Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group. J. Ped. Hemat/Onc 2001, 23: 225-233.

5. Hurwitz, MD, Burger, PC, Goldthwaite PT, Tihan, T, Wharam, MD, Fisher PG. Prognostic Implications for Gadolinium Enhancement of the Meninges in Low-Grade Astrocytomas of Childhood.
Ped Neurosurg 2001: 34 (2) 88-93.

6. Raney, RB, Maurer, HM, Anderson, JR, Andrassy, RJ, Donaldson, SS, Qualman, SJ, Wharam MD, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 2001, 5: 9-15.

7. Donaldson, SS, Meza, J, Breneman, JC, Crist, WM, Laurie, F, Qualman, SJ, Wharam, MD. Results from the IRS-IV Randomized Trial of Hyperfractionated Radiotherapy in Children with Rhabdomyosarcoma-A Report From The IRSG. Int. J. Radiation Oncology Biol. Phys 2001, 51: (3) 718-728.

8. Raney, RB, Meza, J, Anderson, JR, Fryer, CJ, Donaldson, SS, Breneman, JC, Fitzgerald TJ, Gehan EA, Michalski, JM, Ortega, JA, Qualman, SJ, Sandler, E, Wharam, MD, Wiener, ES, Maurer, HM, Crist, WM. Treatment of Children and Adolescents with Localized Parameningeal Sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group Protocols IRS-II Through-IV, 1978-1997.
Med Pediatr Oncol 2002, 38:22-32.

9. Baker, KS, Anderson, JR, Lobe, TE, Wharam, MD, Qualman, SJ, Raney, RB, Ruymann, FB, Womer, RB, Meyer, WH, Link MP, Crist, WM. Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosaracoma: A Report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol, 2002, 20: (22) 4428-4433.

10. Breneman, JC, Lyden E, Pappo AS, Link, MP, Anderson, JR, Parham, DM, Qualman, SJ, Wharam, MD, Donaldson, SS, Maurer, HM, Meyer, WH, Baker, KS, Paidas CN, Crist, WM. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma study IV. J Clin Oncol, 2003, 21:78-84.

11. Pappo, AS, Meza, JL, Donaldson, SS, Wharam, MD, Wiener, ES, Qualman, SJ, Harold, MM, Crist, WM. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: Lesions learned from Intergroup Rhabdomyosarcoma Studies III and IV. J Clin Oncol, 2003, 21: (4) 638-645.

Abstracts

1. Hawkins, M, Anderson, JR, Meza, JL, Fryer, C, Raney, RB, Ruymann, FB, Breneman, J, Qualman, SF,
Wiener, E, Wharam, MD et al. Improved Outcome for Patients with Middle Ear Rhabdomyosarcoma: A Children’s Oncology Group Study. J Clin Oncol 2001, 19: (12) 3073-3079.

2. Williams, M, Anderson, JR, Meza, JL, Fryer, C, Raney, RB, Ruymann, FB, Breneman, SJ. Wiener, Wharam, MD et al. Intergroup Rhabdomyosarcoma study-IV: Results for Patients with Nonmetastatic Disease. J Clin Oncol 2001, 19:3091-3102.

3. Breitfeld, PP, Lyden, E, Raney, B, Teot, LA, Wharam, MD, Lobe, T, Crist, WM, Maurer, HM, Donaldson, SS, Ruymann, RB. Ifosfamide and Etoposide are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma when Administered with Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group. J. Ped. Hemat/Onc 2001, 23: 225-233.

4. Hurwitz, MD, Burger, PC, Goldthwaite PT, Tihan, T, Wharam, MD, Fisher PG. Prognostic Implications for Gadolinium Enhancement of the Meninges in Low-Grade Astrocytomas of Childhood.
Ped Neurosurg 2001: 34 (2) 88-93.

5. Raney, RB, Maurer, HM, Anderson, JR, Andrassy, RJ, Donaldson, SS, Qualman, SJ, Wharam MD, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 2001, 5: 9-15.

6. Donaldson, SS, Meza, J, Breneman, JC, Crist, WM, Laurie, F, Qualman, SJ, Wharam, MD. Results from the IRS-IV Randomized Trial of Hyperfractionated Radiotherapy in Children with Rhabdomyosarcoma-A Report From The IRSG. Int. J. Radiation Oncology Biol. Phys 2001, 51: (3) 718-728.

7. Raney, RB, Meza, J, Anderson, JR, Fryer, CJ, Donaldson, SS, Breneman, JC, Fitzgerald TJ, Gehan EA, Michalski, JM, Ortega, JA, Qualman, SJ, Sandler, E, Wharam, MD, Wiener, ES, Maurer, HM, Crist, WM. Treatment of Children and Adolescents with Localized Parameningeal Sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group Protocols IRS-II Through-IV, 1978-1997.
Med Pediatr Oncol 2002, 38:22-32.

8. Baker, KS, Anderson, JR, Lobe, TE, Wharam, MD, Qualman, SJ, Raney, RB, Ruymann, FB, Womer, RB, Meyer, WH, Link MP, Crist, WM. Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosaracoma: A Report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol, 2002, 20: (22) 4428-4433.

9. Breneman, JC, Lyden E, Pappo AS, Link, MP, Anderson, JR, Parham, DM, Qualman, SJ, Wharam, MD, Donaldson, SS, Maurer, HM, Meyer, WH, Baker, KS, Paidas CN, Crist, WM. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma study IV. J Clin Oncol, 2003, 21:78-84.

10. Pappo, AS, Meza, JL, Donaldson, SS, Wharam, MD, Wiener, ES, Qualman, SJ, Harold, MM, Crist, WM. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: Lesions learned from Intergroup Rhabdomyosarcoma Studies III and IV. J Clin Oncol, 2003, 21: (4) 638-645.